Principal Financial Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-24,702	Closed	-$532K	–	2374
2024 Q2	$532K	Sell	24,702 -6,072	-20%	-$139K	﹤0.01%	1938
2024 Q1	$829K	Buy	30,774 +12,811	+71%	+$364K	﹤0.01%	1895
2023 Q4	$538K	Buy	17,963 +661	+4%	+$14.6K	﹤0.01%	1950
2023 Q3	$355K	Sell	17,302 -28	-0.2%	-$509	﹤0.01%	2015
2023 Q2	$344K	Buy	17,330 +1,333	+8%	+$26.9K	﹤0.01%	2040
2023 Q1	$274K	Buy	15,997 +2,268	+17%	+$44.4K	﹤0.01%	2105
2022 Q4	$269K	Buy	13,729 +1,752	+15%	+$32.3K	﹤0.01%	2130
2022 Q3	$191K	Buy	+11,977	New	+$187K	﹤0.01%	2217
2021 Q4	–	Sell	-20,614	Closed	-$616K	–	2610
2021 Q3	$616K	Buy	20,614 +278	+1%	+$10.1K	﹤0.01%	2118
2021 Q2	$900K	Buy	20,336 +97	+0.5%	+$4.21K	﹤0.01%	2063
2021 Q1	$898K	Buy	20,239 +211	+1%	+$11.6K	﹤0.01%	2020
2020 Q4	$1.1M	Buy	20,028 +9,209	+85%	+$336K	﹤0.01%	1925
2020 Q3	$247K	Buy	10,819 +57	+0.5%	+$1.4K	﹤0.01%	2159
2020 Q2	$225K	Buy	+10,762	New	+$194K	﹤0.01%	2157